The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Arquivos Brasileiros de Cardiologia
()
Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
Paulo Eduardo Ballvé Behr,
Emilio Hideyuki Moriguchi,
Iran Castro,
Luiz Carlos Bodanese,
Oscar Pereira Dutra,
Paulo Ernesto Leães,
Pedro Pimentel Filho
Affiliations
Paulo Eduardo Ballvé Behr
Emilio Hideyuki Moriguchi
Iran Castro
Luiz Carlos Bodanese
Oscar Pereira Dutra
Paulo Ernesto Leães
Pedro Pimentel Filho
DOI
https://doi.org/10.5935/abc.20180133
Journal volume & issue
Vol. 111, no. 1
pp. 104 – 108
Abstract
Read online
No abstracts available.
Keywords
Cardiovascular Diseases/complications
Cardiovascular Diseases/mortality
Coronary Artery Disease
Proprotein Convertase 9
Hyperlipoproteinemia Type II
Ezetimibe, Simvastatin Drug Combination
WeChat QR code
Close